A biodegradable periodontal chip releasing 2.5mg Chlorhexidine Gluconate over a period of 10 days

Novel OTC formulation

Novel Formulation of a well-known US OTC Brand

Omeprazole DR Tablets

Proprietary Delayed Release Tablet Formulation of Omeprazole OTC

Complex Injectable

Complex injectable product equivalent to a well-known brand in the oncology field; Co-developed with CSPC Pharma

ViePax® XR
(Venlafaxine XR tablets)

Proprietary Extended Release Tablet formulation bioequivalent to capsule Effexor XR capsules

Contact Us
* Required field
We are always happy to hear from you

Dexcel Pharma does not have any operations in nor any opportunities for internships or employment in the United States. If you have received an unsolicited offer of employment or have responded to an online job posting promising employment with Dexcel Pharma in the United States, we suggest that you contact your local police or the FBI through its Internet Crime Complaint Center website

Or Akiva Corporate Headquarters

1 Dexcel St., Or Akiva, 3060000, Israel

T. +972 (0) 4 636 4000

E. w.


Nahum Haftzadi 21,

Givat Shaul, Jerusalem, 9123901

T. +972 (0) 2 589 8242


Hakidma 10, Northern High-tech Park,

Yokneam 2069200

T. +972 (0) 4 909 3801

U.K Dexcel Pharma Ltd

7 Sopwith Way, Drayton Fields Daventry,

Northamptonshire NN11 8PB UK

T. +44 (0)1327 312 266


Germany Dexcel Pharma GmbH

Carl-Zeiss-Straße 2, D-63755 Alzenau

T. +49 (0) 6023 94800



Singapore License holder

AmediusTec Ltd

4 Loyang Way 1 Singapore 508708

T. +65 6287 2185

Distributor Apex Pharma Marketing Pte Ltd.